| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/23/2003 | CN1431308A Method for preparing growth factor of recombining endothelial cells of human blood vessel |
| 07/23/2003 | CN1431224A EJOI coding albumen of gene related to ovary growth of mitten crab |
| 07/23/2003 | CN1431019A Propolis capsule of superoxide dismutase |
| 07/23/2003 | CN1431018A Syncretic protein product of human methionine enkephalin interferon alpha-m with anti-HSV infection and easy pain |
| 07/23/2003 | CN1431017A Microcapsule meterial for durative releasing two factors for restraining new-born blood vessels and its preparing method |
| 07/23/2003 | CN1431016A Compositions of health care food for regulating blood sugar and fat as well as its preparing method |
| 07/23/2003 | CN1430994A Chinese medical prepn. for preventing and curing cardiovascular, cerebrovascular diseases and its prodn. method |
| 07/23/2003 | CN1115412C Pro-Urokinase mutants |
| 07/23/2003 | CN1115167C Medical compsn. for treating leukoderma |
| 07/23/2003 | CN1115148C Skin penetration enhancing components |
| 07/23/2003 | CN1115145C Improving tolerability of pharmaceutically active beta-amino acids |
| 07/22/2003 | USRE38202 Antibodies specific for a haemostatic protein, their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 07/22/2003 | US6596923 Methods and compositions to identify swine genetically resistant to F18 E. coli associated diseases |
| 07/22/2003 | US6596867 Bone disorders |
| 07/22/2003 | US6596861 Subjecting reaction mixture comprising a bacterial polysaccharide, an amino compound and a reducing agent to microwave radiation; useful in conjugating polysaccharides to polypeptides and vaccine development |
| 07/22/2003 | US6596853 Nucleotide sequences coding polypeptide for use in the treatment of cancer and prevention of infections |
| 07/22/2003 | US6596852 Antibodies that bind the cytokine designated LERK-5 |
| 07/22/2003 | US6596851 Antibody for use in the treatment of cell proliferative disorders |
| 07/22/2003 | US6596850 Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same |
| 07/22/2003 | US6596848 Antibodies to NIMA interacting proteins |
| 07/22/2003 | US6596847 Tissue factor protein variants |
| 07/22/2003 | US6596791 Polymer complexes of glucuronoglucanes |
| 07/22/2003 | US6596778 β-endorphin peptides for treating muscle-wasting diseases |
| 07/22/2003 | US6596754 Preventives/remedies for multiple organ failure |
| 07/22/2003 | US6596701 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
| 07/22/2003 | US6596698 Localized arterial transduction of RB2/pl30 via a viral vector at the time of angioplasty drastically reduces neointimal hyperplasia and prevents restenosis |
| 07/22/2003 | US6596693 Dipeptide apoptosis inhibitors and the thereof |
| 07/22/2003 | US6596692 Substance P analogs for the treatment of cancer |
| 07/22/2003 | US6596691 Administering therapeutically effective amount of bactericidal/permeability-increasing protein product to a human suffering from meningococcemia |
| 07/22/2003 | US6596690 Stimulating proliferation of the bone marrow cell or protecting the bone marrow cell from the toxicity caused by chemotherapy or irradiation |
| 07/22/2003 | US6596689 Therapeutic method using fucose-containing proteoglycan or acidic glycan |
| 07/22/2003 | US6596687 Cell adhesion inhibitors |
| 07/22/2003 | US6596536 Monoclonal antibody for use in the treatment and diagnosis of autoimmune and arthritic diseases |
| 07/22/2003 | US6596533 Polypeptide for use in the treatment of infections and cell proliferative disorders |
| 07/22/2003 | US6596526 Furin polypeptides with improved characteristics |
| 07/22/2003 | US6596525 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
| 07/22/2003 | US6596498 Bone stimulating factor |
| 07/22/2003 | US6596493 Diagnosis of lung cancer in mammals; obtain sample, extract nucleotide sequences, screen for methylated nucleotide sequences, compare methylation profile with healthy cells, evaluate for cancer |
| 07/22/2003 | US6596491 Tenascin-C nucleic acid ligands |
| 07/22/2003 | US6596488 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer |
| 07/22/2003 | US6596481 Dual markers |
| 07/22/2003 | US6596477 Treatment and prevention of immunodeficiency virus infection by administration of non-pyrogenic derivatives of lipid A |
| 07/22/2003 | US6596473 Detection of antiapotosis protein; obtain genetically engineered cells, measure viable cells, incubate with antiapoptosis agent, compare with control, evaluate adjustment in apoptosis activity |
| 07/22/2003 | US6596298 Pullulan and antimicrobially effective amounts of thymol, methyl salicylate, eucalyptol and menthol |
| 07/22/2003 | US6596296 Three dimensional matrices for growing cells; controlled delivery of therapeutic agents |
| 07/22/2003 | US6596275 Increasing release of PGE-2, IL-10 and/or IL-4; decreasing expression and secretion of IL-1, IL-12 and/or IFM gamma cytokines; decreasing prescence of CD80, CD86 and/or CD40 antigens; having polylysine-cDNA encoding cell nucleus |
| 07/22/2003 | US6596269 Methods of treating chronic pain |
| 07/22/2003 | US6596268 Viruses for the treatment of cellular proliferative disorders |
| 07/22/2003 | US6596262 Modulated release particles for aerosol delivery |
| 07/22/2003 | US6596261 Maximizing drug delivery to lungs |
| 07/22/2003 | US6596206 Generation of pharmaceutical agent particles using focused acoustic energy |
| 07/22/2003 | CA2294422C Tartrate salt of a substituted dipeptide |
| 07/22/2003 | CA2269923C Pharmaceutical compositions containing plasma protein |
| 07/22/2003 | CA2229775C Recombinant conglutinin and producing method thereof |
| 07/22/2003 | CA2220515C Process for producing erythropoietin containing no animal proteins |
| 07/22/2003 | CA2109320C Peptide nucleic acids |
| 07/22/2003 | CA2033085C Use of vaccine preparations containing adenyl cyclase or adenyl cyclase producing bacteria as protecting antigens against bordetella effects |
| 07/17/2003 | WO2003058206A1 Systems and methods for the analysis of protein phosphorylation |
| 07/17/2003 | WO2003058203A2 Extended glucagon-like peptide-1 analogs |
| 07/17/2003 | WO2003057926A1 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 07/17/2003 | WO2003057911A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy |
| 07/17/2003 | WO2003057898A2 Methods and materials for modulating p2x2 |
| 07/17/2003 | WO2003057888A1 Cell-specific expression/replication vector |
| 07/17/2003 | WO2003057884A1 Human serum albumin-timp2 fusion protein, a polynucleotide encoding the same and a method of producing the human serum albumin-timp2 fusion protein |
| 07/17/2003 | WO2003057869A1 Regulation of human sulfatase |
| 07/17/2003 | WO2003057865A1 Composition and method of creating, regenerating and repairing tissues using a cell-carrying biological implant which is enriched with a platelet concentrate and supplements |
| 07/17/2003 | WO2003057862A2 Transdifferentiation of pancreatic acinar cells |
| 07/17/2003 | WO2003057856A2 Dominant negative proteins and methods thereof |
| 07/17/2003 | WO2003057854A2 Novel proteins and nucleic acids encoding same |
| 07/17/2003 | WO2003057849A2 Telomere-encoding synthetic dna nanocircles, and their use for the elongation of telomere repeats |
| 07/17/2003 | WO2003057847A2 METHODS AND MATERIALS FOR MODULATING ENaC-BETA |
| 07/17/2003 | WO2003057840A2 Compositions for dna mediated gene silencing |
| 07/17/2003 | WO2003057835A2 Pak5-related compositions and methods |
| 07/17/2003 | WO2003057831A2 Dtat fusion toxin |
| 07/17/2003 | WO2003057829A2 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 07/17/2003 | WO2003057828A2 Method of producing glycoproteins having reduced complex carbohydrates in mammalian cells |
| 07/17/2003 | WO2003057827A2 Insulin-responsive dna binding protein-1 and methods to regulate insulin-responsive genes |
| 07/17/2003 | WO2003057826A2 SOLUBLE GLcNAC PHOSPHOTRANSFERASE |
| 07/17/2003 | WO2003057822A2 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 07/17/2003 | WO2003057821A2 Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses |
| 07/17/2003 | WO2003057820A2 Peptide activators of vegf |
| 07/17/2003 | WO2003057731A2 Human pheromone receptors |
| 07/17/2003 | WO2003057729A2 Mammal prolactin variants |
| 07/17/2003 | WO2003057728A1 A novel splice variant of myd88 and uses thereof |
| 07/17/2003 | WO2003057726A1 Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants |
| 07/17/2003 | WO2003057725A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 07/17/2003 | WO2003057724A1 Dab9 DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME |
| 07/17/2003 | WO2003057722A2 Cyclic tetrapeptide compound and use thereof |
| 07/17/2003 | WO2003057721A2 Substituted amino carboxamides for the treatment of alzheimer's disease |
| 07/17/2003 | WO2003057720A2 Recovery of biofilament proteins from biological fluids |
| 07/17/2003 | WO2003057714A2 A method of developing an anti-protein and regulation of a cellular function by administering an effective amount of the anti-protein |
| 07/17/2003 | WO2003057711A2 Isolated cytokine receptor licr-2 |
| 07/17/2003 | WO2003057666A2 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057650A2 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate |
| 07/17/2003 | WO2003057257A1 Cc10 inhibits th2 cytokines and eotaxins involved in allergic diseases |
| 07/17/2003 | WO2003057246A1 Proteases producing an altered immunological response and methods of making and using the same |
| 07/17/2003 | WO2003057245A1 Compositions for improving lipid metabolism |
| 07/17/2003 | WO2003057244A2 Use of amylin agonists to modulate triglycerides |
| 07/17/2003 | WO2003057242A1 Use of erythropoietin for the preventive or curative treatment of cardiac failure |
| 07/17/2003 | WO2003057241A1 Agents promoting the proliferation and/or differentiation of hematopoietic stem cells and/or hematopoietic precursor cells |